Covid result in 30 secs? India, Israel conducting tests for potential tech

Israeli Ambassador to India Ron Malka on Friday visited the special testing site created at the Dr Ram Manohar Lohia (RML) Hospital to witness the ongoing trials

medicos, doctors, coronavirus, coronavirus tests, doctors, coronavirus, coronavirus tests, doctors, coronavirus
Medics work on samples collected from media professionals for Covid-19 tests, at a special testing centre set up by the Delhi government at Patel Nagar in New Delhi | Photo: PTI
Press Trust of India New Delhi
4 min read Last Updated : Jul 31 2020 | 7:56 PM IST

Israel and India are conducting trials here on a large sample of patients for four different kinds of technologies that have the potential to detect Covid-19 in about 30 seconds, including a breath analyser and a voice test, according to an Israeli statement.

Israeli Ambassador to India Ron Malka on Friday visited the special testing site created at the Dr Ram Manohar Lohia (RML) Hospital to witness the ongoing trials being conducted since the last three days for rapid Covid-19 testing, the Israeli release on his visit said.

The rapid testing is being jointly developed in cooperation with the Defense Research and Development Directorate of the Israeli Ministry of Defence, India's Defence Research and Development Organisation, Council of Scientific and Industrial Research and Principal Scientific Advisor, India -- coordinated by the ministries of foreign affairs of Israel and India.

Malka was accompanied by Professor K VijayRaghavan, who is the principal scientific advisor to the prime minister.

"RML hospital is one of the testing sites which has started trials of four different kinds of technologies that have the potential to detect coronavirus in as less as 30 seconds," the statement said.
 

These simple, non-invasive technologies include a voice test that uses artificial intelligence to identify changes in the patient's voice and a breath analyser test which requires the patient to blow into a tube and it detects the virus using terra-hertz waves, it said.

There is also isothermal testing that enables identification of the coronavirus in a saliva sample and a test using polyamino acids that seeks to isolate proteins related to Covid-19, the statement said.

"These trials are being conducted on a large sample of patients in India and if the results validate the effectiveness of the tests, they would be mass manufactured in India and marketed to the world by Israel and India jointly," it said.

Speaking during his visit to the testing site, Malka said, If even one of these tests is successful in detecting the virus in as less as half a minute, it will be the biggest breakthrough in Covid-19 identification that the world has been waiting for."

"By combining advanced Israeli and Indian technology and India's manufacturing prowess, we can find a way to resume our lives and exist alongside the virus till a vaccine is developed," he said.

Professor VijayRaghavan said the translation of cutting-edge basic science and technology to society is seen happening in this deep collaboration.

"What was yesterday considered esoteric research is now being tested for implementation. Such robust tests are the touchstone of science," he said.

Noting that Israel and India share collaborations in every area of science, VijayRaghavan said the friendship and trust between the two countries that has developed over the years have made the ongoing studies happen with speed and quality.

"I am sure that some of these will be successful and result in great value to our countries and to humanity," VijayRaghavan was quoted as saying by the statement.

These trials are a part of a multi-pronged mission visiting India from Israel to cooperate on Covid-19 research and development, further cementing the strategic relationship between the two nations, the statement said.

Earlier this week, arriving on a special plane from Tel Aviv, the Israeli delegation also brought effective treatment and monitoring equipment that reduces exposure of healthcare workers to the virus, and 83 advanced respirators which are otherwise still banned for export in Israel, but have been brought here with a special waiver.

One subscription. Two world-class reads.

Already subscribed? Log in

Subscribe to read the full story →
*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

Topics :CoronavirusDRDOisraelCoronavirus TestsIndia Israel

Next Story